VIDEO: ‘A lot of new data’ on pediatric, adult atopic dermatitis presented at AAD

DENVER — In this video from the American Academy of Dermatology Annual Meeting, Lawrence F. Eichenfield, MD, discusses new treatment data for atopic dermatitis for both children and adults.
Over 260 posters, abstracts and presentations on atopic dermatitis were presented at the meeting, Eichenfield said. Topics ranged from nemolizumab (Nemluvio, Galderma), topical roflumilast (Zoryve, Arcutis), bispecific and trispecific antibodies and biologic oral treatments.
“[There is] a lot of evolution, both in the topical and systemic field,” Eichenfield, chief of pediatric and

Allergy treatment shifts toward precision medicine with tailored immunotherapy, new guidance shows

Until recently, allergy treatment was largely based on average treatment schemes. A patient with pollen allergy would receive a similar therapy to others with the same diagnosis. Today, this model is beginning to change. The latest recommendations published by the European Academy of Allergy and Clinical Immunology in the journal Allergy show that allergen immunotherapy (AIT) is entering the era of precision medicine, and with it, the way we think about allergy itself is evolving.

Smartwatches and GPS devices show promise for tracking environmental impacts on health in real time

As climate change drives more frequent extreme heat and worsening air pollution, researchers are seeking better ways to understand how these exposures affect health in real time. A new pilot study led by researchers at The City University of New York demonstrates the feasibility of combining wearable devices, smartphone location data, and real-time surveys to capture individuals' environmental exposures and their immediate physical and emotional effects.